rs77568474

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS1

The NM_000260.4(MYO7A):​c.1343+50T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000928 in 1,608,020 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00096 ( 1 hom. )

Consequence

MYO7A
NM_000260.4 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.663

Publications

0 publications found
Variant links:
Genes affected
MYO7A (HGNC:7606): (myosin VIIA) This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]
MYO7A Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, PanelApp Australia
  • Usher syndrome type 1B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant nonsyndromic hearing loss 11
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Usher syndrome type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 11-77161165-T-A is Benign according to our data. Variant chr11-77161165-T-A is described in ClinVar as Likely_benign. ClinVar VariationId is 255660.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.000957 (1393/1455814) while in subpopulation SAS AF = 0.00146 (125/85884). AF 95% confidence interval is 0.00125. There are 1 homozygotes in GnomAdExome4. There are 687 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO7ANM_000260.4 linkc.1343+50T>A intron_variant Intron 12 of 48 ENST00000409709.9 NP_000251.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO7AENST00000409709.9 linkc.1343+50T>A intron_variant Intron 12 of 48 1 NM_000260.4 ENSP00000386331.3
MYO7AENST00000458637.6 linkc.1343+50T>A intron_variant Intron 12 of 48 1 ENSP00000392185.2
MYO7AENST00000409619.6 linkc.1310+50T>A intron_variant Intron 13 of 49 1 ENSP00000386635.2

Frequencies

GnomAD3 genomes
AF:
0.000658
AC:
100
AN:
152088
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000970
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000788
AC:
195
AN:
247386
AF XY:
0.000865
show subpopulations
Gnomad AFR exome
AF:
0.000390
Gnomad AMR exome
AF:
0.0000583
Gnomad ASJ exome
AF:
0.00171
Gnomad EAS exome
AF:
0.000112
Gnomad FIN exome
AF:
0.000233
Gnomad NFE exome
AF:
0.000919
Gnomad OTH exome
AF:
0.000667
GnomAD4 exome
AF:
0.000957
AC:
1393
AN:
1455814
Hom.:
1
Cov.:
30
AF XY:
0.000950
AC XY:
687
AN XY:
723510
show subpopulations
African (AFR)
AF:
0.0000900
AC:
3
AN:
33322
American (AMR)
AF:
0.0000674
AC:
3
AN:
44536
Ashkenazi Jewish (ASJ)
AF:
0.00162
AC:
42
AN:
25992
East Asian (EAS)
AF:
0.000379
AC:
15
AN:
39590
South Asian (SAS)
AF:
0.00146
AC:
125
AN:
85884
European-Finnish (FIN)
AF:
0.000244
AC:
13
AN:
53344
Middle Eastern (MID)
AF:
0.000522
AC:
3
AN:
5742
European-Non Finnish (NFE)
AF:
0.00103
AC:
1139
AN:
1107270
Other (OTH)
AF:
0.000831
AC:
50
AN:
60134
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
61
123
184
246
307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000657
AC:
100
AN:
152206
Hom.:
0
Cov.:
32
AF XY:
0.000672
AC XY:
50
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41520
American (AMR)
AF:
0.000196
AC:
3
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5176
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4814
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000971
AC:
66
AN:
68000
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00111
Hom.:
0
Bravo
AF:
0.000589
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.3
DANN
Benign
0.40
PhyloP100
-0.66
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77568474; hg19: chr11-76872211; API